NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/15/2026
Back to search
Official data from USPTO
ID-BASE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/16/2026
Trademark type
Combined
Nice classes
9, 42
Filing date
06/25/2018
Registration date
09/10/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/15/2026
Last transaction
01/16/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
Ottignies, BE
Examiner
BLAZICH,JOAN MICHELE
Current location
Historical data usage
Mark description
The mark consists of a red gear above a blue gear above a light blue gear, followed by the wording "ID-BASE" in a black stylized font, all on a white background.
Holders and representatives
Holders
International Drug Development Institute, en abrégé "IDDI", Société Anonyme
International Drug Development Institute, en abrégé "IDDI", Société Anonyme
Representatives
Sara T. Colburn Cantor Colburn LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computer software for data management and statisticsanalysis and management of clinical data in the field of clinical trials for pharmaceuticalspharmaceutical drug development and pharmaceutical product evaluation; calculating machinesdata processing equipmentcomputers; software in connection with the management of clinical trials for pharmaceutical productssoftware for clinical data management in the field of pharmaceutical product clinical trials
Class 42
Research and design in the field of clinical trials for pharmaceuticalspharmaceutical drug development and pharmaceutical product evaluation; design and development of computer hardware and software relating to the management of clinical trials for pharmaceuticals; rental of software relating to the management of clinical trials for pharmaceuticals; rental of software connection with the management of clinical trials for pharmaceutical products
Publications
History of USPTO decisions and trademark events.
29 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
01/15/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/13/2026
ES71
TEAS SECTION 71 RECEIVED
09/09/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/14/2020
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/06/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
01/06/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2019
PUBO
PUBLISHED FOR OPPOSITION
06/25/2019
GPNX
NOTIFICATION PROCESSED BY IB
06/21/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/05/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/05/2019
NPUB
NOTICE OF PUBLICATION
06/05/2019
ALIE
ASSIGNED TO LIE
05/20/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2019
RFNT
REFUSAL PROCESSED BY IB
11/24/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/02/2018
RFRR
REFUSAL PROCESSED BY MPU
11/01/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/18/2018
CNRT
NON-FINAL ACTION WRITTEN
10/17/2018
DOCK
ASSIGNED TO EXAMINER
10/13/2018
MAFR
APPLICATION FILING RECEIPT MAILED
10/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/09/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/05/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/04/2018
Continuous trademark protection
Get notified about every new filing that threatens ID-BASE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.